|
A phase I dose-escalation study of an all-in-one 5-fluorouracil and leucovorin co-formulation administered after failure of standard treatment. |
| |
|
Consulting or Advisory Role - MSD |
Travel, Accommodations, Expenses - MSD Oncology |
| |
|
Research Funding - FivepHusion |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Bod australia |
Research Funding - FivePhusion (Inst) |
Other Relationship - Servier/Pfizer |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Research Funding - FivepHusion (Inst) |
| |
|
No Relationships to Disclose |
| |
|
Employment - FivepHusion (I) |
Leadership - FivepHusion (I) |
Stock and Other Ownership Interests - FivepHusion |
Research Funding - Race Oncology |
Patents, Royalties, Other Intellectual Property - FivepHusion (I) |
Travel, Accommodations, Expenses - FivepHusion (I) |
| |
|
|
|
Stock and Other Ownership Interests - FivepHusion |
Research Funding - Race Oncology (I) |
Patents, Royalties, Other Intellectual Property - FivepHusion |
Travel, Accommodations, Expenses - FivepHusion |
| |
|
Employment - Actinogen; FivepHusion |
Leadership - Actinogen; FivepHusion |
Stock and Other Ownership Interests - Actinogen; Bionomics; CSL Limited; FivepHusion; Immutep; Starpharma |
Consulting or Advisory Role - Actinogen; FivepHusion |
Speakers' Bureau - Actinogen; FivepHusion |
Patents, Royalties, Other Intellectual Property - FivepHusion |
Travel, Accommodations, Expenses - Actinogen; FivepHusion |
| |
|
|
Travel, Accommodations, Expenses - FivepHusion |
| |
|
No Relationships to Disclose |